HCA Reports Fourth Quarter 2017 Results, Initiates Quarterly Dividend, Increases Capital Spending and Provides 2018 Guidance

Go back to HCA Reports Fourth Quarter 2017 Results, Initiates Quarterly Dividend, Increases Capital Spending and Provides 2018 Guidance

HCA Holdings (HCA) PT Raised to $114 at Baird Following 4Q

January 31, 2018 8:27 AM EST

Baird raised its price target on HCA Holdings (NYSE: HCA) to $114.00 (from $104.00) while maintaining a Outperform rating following the company's 4Q. 4Q17 revenues of $11.6b beat consensus by 3.2%. EBITDA of $2.36b beat consensus by 7.8% and EPS of $1.30 missed consensus of $1.87 due to an $0.81... More

HCA Holdings (HCA) PT Raised to $120 at Leerink Partners

January 31, 2018 7:45 AM EST

Leerink Partners raised its price target on HCA Holdings (NYSE: HCA) to $120.00 (from $105.00) while maintaining a Outperform rating.

Analyst Ana Gupte cited 1) solid volumes and 4Q beat 2) 2018 guidance well ahead of consensus 3) $500 MM cash tax reform tailwind leveling the playing field with HCA's... More

HCA Holdings (HCA) Reports Q4 EPS of $1.30

January 30, 2018 8:34 AM EST

HCA Holdings (NYSE: HCA) reported Q4 EPS of $1.30, $0.57 worse than the analyst estimate of $1.87. Revenue for the quarter came in at $11.56 billion versus the consensus estimate of $11.2 billion.

Results for the fourth quarter of 2017 include a non-cash increase in the Companys provision... More